Clinical Trial Update: Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up

View source ↗

Summary

This document provides an update on a post-market clinical follow-up evaluating safety, performance, and clinical benefit of pacing the left bundle branch area.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Block
• Bradycardia
• Bundle Branch Block
• Sinus Node Dysfunction

Drugs mentioned

• Left Bundle Branch Area Pacing System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Bradycardia, Atrioventricular Block | Status: RECRUITING